Skip to main content

QLT DRC RET IRD 04: A Study of the Efficacy and Safety of QLT091001 in Subjects with Inherited Retinal Disease (IRD) Caused by Mutation in Retinal Pigment Epithelium Protein 65 (RPE65) or Lecithin:Retinol Acyltransferase (LRAT)

Research Grant
Duke Scholars

Administered By

Ophthalmology

Awarded By

QLT, Inc.

Start Date

June 28, 2016

End Date

June 27, 2021
 

Administered By

Ophthalmology

Awarded By

QLT, Inc.

Start Date

June 28, 2016

End Date

June 27, 2021